MGRB Q1 2026 Earnings Earnings Beat Estimates Amidst Modest Stock Decline Castle Biosciences Q1 2026 Earnings Narrowly Beats EPS Estimates but Stock Declines SLNO Q1 2026 Earnings EPS Misses Expectations Amid Lack of Revenue KRMD Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline CGNT Q1 2026 Earnings EPS Surges Past Estimates by 126 but Stock Slips Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline